Overview:
About Colorectal Cancer
Scientific Literature
FDA Clearance
FAQ
Conference Presentations
Physician Testimonies
Become a Partner
Onko-Sure is manufactured at our GMP-regulated, ISO 13485(2003) certified facility in Tustin, California. Onko-Sure™ is sold to third party distributors, who then sell directly to CLIA certified reference laboratories in the United States as well as clinical reference labs, hospital laboratories and physician operated laboratories in the international market. We also sell to other international markets through distributor agreements.
Our Onko-Sure™ cancer test kits are currently sold in the form of a 96 well test plate, which, after standards are applied, 41 individual tests can be run in duplicate. These tests are typically run in a clinical reference laboratory with test results determined by using a micro-titer reading analyzer. Results are sent to the attending physician who then relays those results to the patient. Typically, a patient can receive results within 3-5 days from the blood draw date.
How Onko-Sure™ Works
While the production of Fibrin and Fibrinogen Degradation Products (FDP) is restricted in healthy individuals, FDP are over produced by cancer cells, which release proteolytic enzymes such as plasmin and thrombin. Current assays for FDP usually measure a specific FDP component, such as D-dimer, as a representative of this group; whereas the Onko-Sure™ test detects the full complement of FDP. Onko-Sure™ acts as a “barometer for cancer” by simultaneously measuring the multiple FDP species that may be underestimated by other tests.
REQUEST MORE INFORMATION.
Onko-Sure / DR-70 References
Small-Howard, AL & Harris H (2010) J Immunoassay & Immunochem 31, 131-147.
Schaffrath, M et al. (2006) German J Obstetrics and Gynocology 66, 68-75.
Lee, K.H et al. (2006) Immune Network 6, 43-51.
Adonis, M et al. (2005) Toxicol Lett. 159:32-7.
Li, X. et al. (2005) Br J Oral Maxillofac Surg 43, 513-515.
Adonis, M et al. (2005) Xenobiotica 35:519-30.
Kerber, A. et al. (2004) Aliment Pharmacol Ther 20, 983-987.
Rucker, P et al. (2004) Analytical Letters 37, 2965-2976.
Wu, DF et al. (1999) Analytical Letters 32, 1351-1362.
Ding, L. et al. (1999) Chongqing Med J 28, 1-3.
Wu, D et al. (1998) J Immunoassay 19, 63-72.